BCRX — BioCryst Pharmaceuticals, Inc. stock price, charts and financials

QT57BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.02
+0.21+2.38%
OverviewShort InterestFilings
BCRXQT57BioCryst Pharmaceuticals, Inc.·NASDAQ
9.02+2.38%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20268-K/ACurrent report (amended)
Jun 29, 20268-KCurrent report
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
May 04, 20268-KCurrent report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 23, 2026ARSAnnual report to shareholders
#1 / 25 of 390
Page
▼
/ 16